228 related articles for article (PubMed ID: 26048991)
1. Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-d-aspartate Receptors.
Kunda S; Yuan Y; Balsara RD; Zajicek J; Castellino FJ
J Biol Chem; 2015 Jul; 290(29):18156-18172. PubMed ID: 26048991
[TBL] [Abstract][Full Text] [Related]
2. Discerning the Role of the Hydroxyproline Residue in the Structure of Conantokin Rl-B and Its Role in GluN2B Subunit-Selective Antagonistic Activity toward N-Methyl-d-Aspartate Receptors.
Yuan Y; Balsara RD; Zajicek J; Kunda S; Castellino FJ
Biochemistry; 2016 Dec; 55(51):7112-7122. PubMed ID: 27981829
[TBL] [Abstract][Full Text] [Related]
3. Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.
Teichert RW; Jimenez EC; Twede V; Watkins M; Hollmann M; Bulaj G; Olivera BM
J Biol Chem; 2007 Dec; 282(51):36905-13. PubMed ID: 17962189
[TBL] [Abstract][Full Text] [Related]
4. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
Sheng Z; Prorok M; Castellino FJ
Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
[TBL] [Abstract][Full Text] [Related]
5. Antagonist properties of Conus parius peptides on N-methyl-D-aspartate receptors and their effects on CREB signaling.
Kunda S; Cheriyan J; Hur M; Balsara RD; Castellino FJ
PLoS One; 2013; 8(11):e81405. PubMed ID: 24260577
[TBL] [Abstract][Full Text] [Related]
6. Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.
Gowd KH; Han TS; Twede V; Gajewiak J; Smith MD; Watkins M; Platt RJ; Toledo G; White HS; Olivera BM; Bulaj G
Biochemistry; 2012 Jun; 51(23):4685-92. PubMed ID: 22594498
[TBL] [Abstract][Full Text] [Related]
7. Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.
Huang L; Balsara RD; Castellino FJ
J Neurosci Res; 2014 Dec; 92(12):1767-74. PubMed ID: 25043917
[TBL] [Abstract][Full Text] [Related]
8. Conantokin-P, an unusual conantokin with a long disulfide loop.
Gowd KH; Twede V; Watkins M; Krishnan KS; Teichert RW; Bulaj G; Olivera BM
Toxicon; 2008 Aug; 52(2):203-13. PubMed ID: 18586049
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
[TBL] [Abstract][Full Text] [Related]
10. From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypes.
Platt RJ; Curtice KJ; Twede VD; Watkins M; Gruszczyński P; Bulaj G; Horvath MP; Olivera BM
Toxicon; 2014 Apr; 81():67-79. PubMed ID: 24508768
[TBL] [Abstract][Full Text] [Related]
11. Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R.
Blandl T; Zajicek J; Prorok M; Castellino FJ
J Biol Chem; 2001 Mar; 276(10):7391-6. PubMed ID: 11096077
[TBL] [Abstract][Full Text] [Related]
12. Role of gamma-carboxyglutamic acid in the calcium-induced structural transition of conantokin G, a conotoxin from the marine snail Conus geographus.
Rigby AC; Baleja JD; Li L; Pedersen LG; Furie BC; Furie B
Biochemistry; 1997 Dec; 36(50):15677-84. PubMed ID: 9398296
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid replacement results in the Ca2+-induced self-assembly of a helical conantokin-based peptide.
Dai Q; Castellino FJ; Prorok M
Biochemistry; 2004 Oct; 43(41):13225-32. PubMed ID: 15476416
[TBL] [Abstract][Full Text] [Related]
14. Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity.
Haack JA; Rivier J; Parks TN; Mena EE; Cruz LJ; Olivera BM
J Biol Chem; 1990 Apr; 265(11):6025-9. PubMed ID: 2180939
[TBL] [Abstract][Full Text] [Related]
15. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
Sheng Z; Dai Q; Prorok M; Castellino FJ
Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
[TBL] [Abstract][Full Text] [Related]
16. Characterization of conantokin Rl-A: molecular phylogeny as structure/function study.
Gowd KH; Watkins M; Twede VD; Bulaj GW; Olivera BM
J Pept Sci; 2010 Aug; 16(8):375-82. PubMed ID: 20572027
[TBL] [Abstract][Full Text] [Related]
17. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.
Twede VD; Teichert RW; Walker CS; Gruszczyński P; Kaźmierkiewicz R; Bulaj G; Olivera BM
Biochemistry; 2009 May; 48(19):4063-73. PubMed ID: 19309162
[TBL] [Abstract][Full Text] [Related]
18. The roles of individual gamma-carboxyglutamate residues in the solution structure and cation-dependent properties of conantokin-T.
Warder SE; Prorok M; Chen Z; Li L; Zhu Y; Pedersen LG; Ni F; Castellino FJ
J Biol Chem; 1998 Mar; 273(13):7512-22. PubMed ID: 9516452
[TBL] [Abstract][Full Text] [Related]
19. Conantokins: inhibitors of ion flow through the N-methyl-D-aspartate receptor channels.
Castellino FJ; Prorok M
Curr Drug Targets; 2000 Nov; 1(3):219-35. PubMed ID: 11465072
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships of the NMDA receptor antagonist conantokin peptides.
Prorok M; Castellino FJ
Curr Drug Targets; 2001 Sep; 2(3):313-22. PubMed ID: 11554555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
